{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T17:40:04Z","timestamp":1749318004249,"version":"3.41.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Patients with aortic stenosis are at risk for developing hypertension. The selection of antihypertensives is a topic of debate due to a lack of consensus regarding their safety. This article provides an overview of antihypertensives used in patients with aortic stenosis, focusing on renin-angiotensin system inhibitors, beta-blockers, diuretics, and vasodilators.<\/jats:p>","DOI":"10.1097\/01.npr.0000769732.71640.4c","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T18:00:48Z","timestamp":1629741648000},"page":"14-22","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Antihypertensive therapy in patients with moderate to severe aortic stenosis"],"prefix":"10.1097","volume":"46","author":[{"given":"Mohamed Toufic","family":"El Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexi","family":"Bueckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"5","key":"R1-20250607","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamacardio.2016.2060","article-title":"Aortic valve stenosis","volume":"1","author":"Patel","year":"2016","journal-title":"JAMA Cardiol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"i5425","DOI":"10.1136\/bmj.i5425","article-title":"Aortic stenosis: diagnosis and management","volume":"355","author":"Zakkar","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"R3-20250607","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"9667","key":"R4-20250607","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(09)60211-7","article-title":"Aortic stenosis","volume":"373","author":"Carabello","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"R5-20250607","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","article-title":"Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"30","author":"Baumgartner","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"R6-20250607","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/1570161116666180101165306","article-title":"Aortic stenosis, aortic regurgitation and arterial hypertension","volume":"17","author":"Katsi","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"R7-20250607","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4250\/jcvi.2018.26.e9","article-title":"Antihypertensive treatment in severe aortic stenosis","volume":"26","author":"Kang","year":"2018","journal-title":"J Cardiovasc Imaging"},{"issue":"6","key":"R8-20250607","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.115.021213","article-title":"Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis: the simvastatin ezetimibe in aortic stenosis study (SEAS)","volume":"134","author":"Nielsen","year":"2016","journal-title":"Circulation"},{"key":"R9-20250607","doi-asserted-by":"crossref","DOI":"10.5604\/01.3001.0012.8290","article-title":"Angiotensin-converting enzyme inhibitors modulate the activation of the tissue factor pathway within aortic valves in patients with aortic stenosis: Links between blood coagulation and inflammation","author":"Natorska","year":"2018"},{"issue":"18","key":"R10-20250607","doi-asserted-by":"crossref","first-page":"e016911","DOI":"10.1161\/JAHA.120.016911","article-title":"Renin-angiotensin system blockade in aortic stenosis: implications before and after aortic valve replacement","volume":"9","author":"Goel","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"R11-20250607","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.amjcard.2017.02.037","article-title":"Effect of renin-angiotensin blockers on left ventricular remodeling in severe aortic stenosis","volume":"119","author":"Goh","year":"2017","journal-title":"Am J Cardiol"},{"issue":"4","key":"R12-20250607","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.amjcard.2017.11.013","article-title":"Relation between renin-angiotensin system blockers and survival following isolated aortic valve replacement for aortic stenosis","volume":"121","author":"Magne","year":"2018","journal-title":"Am J Cardiol"},{"issue":"8","key":"R13-20250607","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurheartj\/ehz769","article-title":"Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries","volume":"41","author":"Chen","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"R14-20250607","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ehjcvp\/pvw027","article-title":"Is the use of renin-angiotensin system inhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysis","volume":"3","author":"Andersson","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"8","key":"R15-20250607","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archinte.165.8.858","article-title":"Angiotensin-converting enzyme inhibitors and change in aortic valve calcium","volume":"165","author":"O'Brien","year":"2005","journal-title":"Arch Intern Med"},{"issue":"1","key":"R16-20250607","first-page":"34","article-title":"Metoprolol treatment reduces hemodynamic and metabolic overload in patients with asymptomatic aortic valve stenosis: a randomized double-blind placebo controlled trial","volume":"38","author":"Hansson","year":"2017","journal-title":"Eur Heart J"},{"issue":"12","key":"R17-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.117.006709","article-title":"Antihypertensive treatment with \u03b2-blockade in patients with asymptomatic aortic stenosis and association with cardiovascular events","volume":"6","author":"Bang","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2019.09.007","article-title":"Antihypertensive treatment with calcium channel blockers in patients with moderate or severe aortic stenosis: relationship with all-cause mortality","volume":"298","author":"Saeed","year":"2020","journal-title":"Int J Cardiol"},{"issue":"10","key":"R19-20250607","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00380-019-01411-3","article-title":"Clinical safety and efficacy of tolvaptan for acute phase therapy in patients with low-flow and normal-flow severe aortic stenosis","volume":"34","author":"Mitsui","year":"2019","journal-title":"Heart Vessels"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2020.02.017","article-title":"Short-term effects of low-dose tolvaptan in acute decompensated heart failure patients with severe aortic stenosis: the LOHAS registry","volume":"305","author":"Watanabe","year":"2020","journal-title":"Int J Cardiol"},{"issue":"4","key":"R21-20250607","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.mayocp.2018.01.020","article-title":"Management of patients with aortic valve stenosis","volume":"93","author":"Kanwar","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"R22-20250607","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/CIRCULATIONAHA.116.023997","article-title":"Medical treatment of aortic stenosis","volume":"134","author":"Marquis-Gravel","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"R23-20250607","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.annemergmed.2015.03.027","article-title":"Complications associated with nitrate use in patients presenting with acute pulmonary edema and concomitant moderate or severe aortic stenosis","volume":"66","author":"Claveau","year":"2015","journal-title":"Ann Emerg Med"}],"container-title":["The Nurse Practitioner"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000769732.71640.4c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T17:01:35Z","timestamp":1749315695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000769732.71640.4c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.npr.0000769732.71640.4c","relation":{},"ISSN":["0361-1817"],"issn-type":[{"type":"print","value":"0361-1817"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}